Medically reviewed by Adam Russell, PA-C
The phrase “military testosterone testing” can make the 2026 policy sound broader than it is. The Defense Health Agency says male service members age 30 and older will undergo testosterone-deficiency screening during periodic health assessments, entry examinations, or annual physicals. Men under 30 may be screened on request or when a clinician identifies clinical indicators.
Importantly, the DHA describes screening as a structured symptom and risk-factor assessment. A blood test may become part of the clinical evaluation, but the policy should not be interpreted as an automatic annual testosterone blood draw for every man over 30.
What happens after screening?
If screening identifies a possible problem, the clinician can determine what additional evaluation is appropriate. That may include laboratory testing, repeat testing, assessment of other health conditions, or discussion of treatment options.
The DHA’s September guidance says replacement therapy or other hormone treatments may be options when testosterone deficiency exists, with treatment plans decided and monitored by military medical professionals.
Why the policy is controversial
The Endocrine Society responded on September 24, 2026, saying evidence is insufficient to support population-level screening of asymptomatic men with testosterone measurements and raising concerns about false positives and fertility. That does not mean service members should ignore symptoms or testing. It means results require clinical context.
Questions to ask after a positive screen
Ask whether the concern is based on symptoms, risk factors, laboratory results, or all three. Ask whether a second morning testosterone measurement is needed, whether other causes are being evaluated, and what the benefits and risks of each treatment option are.
For a broader overview of treatment and outside-care issues, see Military Testosterone Testing and TRT: What Service Members Should Know in 2026.